SCHEMBL31000264

SCHEMBL31000264

[2H]C([2H])([2H])Oc1cc2ncc(Br)n2nc1C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31639411 0.78 NRAS (0.31) —
SCHEMBL24975689 0.75 PDE10A (0.36) —
SCHEMBL31000221 0.74 DYRK1A (0.38) —
SCHEMBL24975688 0.74 PDE10A (0.34) —
SCHEMBL31000205 0.73 CHRM5 (0.38) —
SCHEMBL31739611 0.70 DYRK1A (0.37) —
SCHEMBL29682761 0.69 FLT3 (0.42) —
SCHEMBL24542495 0.69 FLT3 (0.42) —
SCHEMBL31000261 0.69 IGF1R (0.38) —
SCHEMBL31000231 0.69 NRAS (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658659-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF Children's Hospital Medical Center (US) 2025-12-10 — — EP disclosed
WO-2024163764-A2 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CHILDREN'S HOSPITAL MEDICAL CENTER (US) 2024-08-08 — — WO disclosed
Send feedback